Berberine RCT doses ranged from 500 mg to 1,500 mg/day, with the most-cited 500 mg three times a day with meals (Yin 2008 trial vs metformin). Calculator for goal-specific doses with drug interaction warnings. Past-tense trial data, not a prescription.
Your goal
1,500 mg/day
Target daily dose split across 3 doses with meals (500 mg × 3)
Titration schedule (new users)
To minimize GI side effects (nausea, diarrhea, cramping), start low and ramp up over 1-2 weeks:
| Week | Dose | Schedule | Notes |
|---|---|---|---|
| 1 | 500 mg/day | 1× with largest meal | Assess GI tolerance |
| 2 | 1,000 mg/day | 500 mg × 2 with breakfast + dinner | If well tolerated, continue ramping |
| 3+ | 1,500 mg/day | 500 mg × 3 with each main meal | Full Yin 2008 trial dose |
RCT dose reference (the actual data)
| Trial | Population | Daily dose | Outcome |
|---|---|---|---|
| Yin 2008 (Metabolism) | Newly-diagnosed T2D, n=36 | 1,500 mg (500×3) | HbA1c -0.9% (equivalent to metformin arm) |
| Zhang 2008 (J Clin Endo Metab) | T2D adjunct, n=84 | 1,000 mg (500×2) | FPG -1.0 mmol/L; HbA1c -0.6% |
| Kong 2004 (Nat Med) | Hypercholesterolemia, n=63 | 500 mg × 2 | LDL -25%; TC -29%; TG -35% |
| Wei 2012 (Endocrine) | PCOS, n=89 | 1,500 mg (500×3) | Improved insulin sensitivity, similar to metformin |
| Hu 2012 (Phytomedicine) | Adults with obesity, n=37 | 1,500 mg (500×3) | Weight -5 lb over 12 wk; waist circumference reduction |
Note: 500 mg × 3 daily emerged as the most-cited effective dose because berberine has poor oral bioavailability (~5%) and short half-life — split dosing maintains plasma levels.
Drug interactions — be specific with your prescriber
- Metformin: additive glucose-lowering. Hypoglycemia risk if doses not coordinated. Some prescribers use berberine to reduce metformin dose; do not self-adjust.
- Statins (simvastatin, atorvastatin): berberine inhibits CYP3A4 → elevated statin levels → rhabdomyolysis risk. Avoid combination or seek monitoring.
- Cyclosporine / tacrolimus: berberine raises plasma levels via CYP3A4 inhibition. Do not combine without transplant team approval.
- Warfarin: may potentiate anticoagulant effect; close INR monitoring required.
- Pregnancy / breastfeeding: not recommended — berberine crosses placenta and may displace bilirubin (kernicterus risk in newborns).
- Antibiotics (especially tetracyclines): berberine has antimicrobial activity; may reduce antibiotic effectiveness or cause additive GI effects.
What berberine is NOT
- Not “natural Ozempic.” Berberine modestly lowers blood sugar via AMPK activation; GLP-1 receptor agonists work via different mechanism and have far larger weight-loss effects (15-20% body weight vs ~3-5% for berberine alone).
- Not for type 1 diabetes. Insulin replacement is the only treatment for T1D. Berberine has no role.
- Not a substitute for metformin. Metformin has 60+ years of safety data, cardiovascular outcome trials, and pregnancy data. Berberine has only short-term RCT data.
- Not bioidentical regardless of label. “Standardized to 97% berberine HCl” is common; check the label for actual berberine content per capsule (typically 400-500 mg).